pergolide has been researched along with ergoline in 257 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 191 (74.32) | 18.7374 |
| 1990's | 15 (5.84) | 18.2507 |
| 2000's | 41 (15.95) | 29.6817 |
| 2010's | 10 (3.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, BI; Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ | 2 |
| Bogdanov, MB; Gaĭnetdinov, RR; Kudrin, VS; Raevskiĭ, KS | 1 |
| Pawlikowski, M; Pisarek, H; Stepien, H | 1 |
| Pisarek, H; Stepien, H | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Demichel, P; Moran, A; Roquebert, J; Sauvage, MF | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| Clemens, JA; Foreman, MM; Fuller, RW; Gidda, JS; Hynes, MD; Kornfeld, EC; Nichols, CL; Schaus, JM | 1 |
| Gershanik, O; Rubinstein, M; Schinder, AF; Stefano, FJ | 1 |
| Claustre, Y; Fage, D; Scatton, B; Zivkovic, B | 1 |
| Forster, C; Herrera-Marschitz, M; Ungerstedt, U | 3 |
| Fuller, RW; Hemrick-Luecke, SK; Perry, KW; Toomey, RE | 1 |
| Arnt, J; Hyttel, J | 2 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Andersson, M; Fowler, CJ; Magnusson, O; Thorell, G | 1 |
| Goiny, M; Uvnäs-Moberg, K | 1 |
| Lemberger, L | 1 |
| Goldstein, M; Leibowitz, M; Lieberman, AN | 1 |
| Giardi, A; Maura, G; Raiteri, M | 1 |
| Fuller, RW; Gust, CM | 1 |
| Arnt, J | 3 |
| Cavero, I; Dennis, T; Di Paola, ED; Lhoste, F; Lorrain, J; Payen, B; Scatton, B | 1 |
| Bergstrom, DA; Carlson, JH; Walters, JR | 1 |
| Leander, JD | 1 |
| Jones, JH; Lotti, VJ; Martin, GE; Pettibone, DJ; Taylor, DA; Williams, M; Zrada, MM | 1 |
| Corenblum, B | 1 |
| Kletzky, OA; Shangold, GA | 1 |
| Borenstein, R; Kletzky, OA; Mileikowsky, GN | 1 |
| Kleinberg, DL; Newman, CB | 1 |
| Rinne, UK | 1 |
| Herrera-Marschitz, M; Ungerstedt, U | 3 |
| Friedhoff, AJ; Goldstein, M; Kuga, S; Meller, E | 1 |
| Herrera-Marschitz, M; Ståhle, L; Tossman, U; Ungerstedt, U; Zetterström, T | 2 |
| Delwaide, PJ; Gonce, M | 1 |
| Svensson, L | 1 |
| Di Chiara, G; Frau, R; Imperato, A; Tanda, G | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR; Meyers, DB; Parli, CJ; Smallwood, JK; Toomey, RE | 1 |
| Knapp, R; Kurlan, R; Miller, C; Murphy, G; Shoulson, I | 1 |
| Carboni, E; Deidda, S; Di Chiara, G; Longoni, R | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Bowyer, JF; Weiner, N | 1 |
| Lees, AJ; Stern, GM; Wright, A | 1 |
| Hutchison, JB; Nahorski, SR; Strupish, J | 1 |
| Duvoisin, RC; Sage, JI | 2 |
| Tossman, U; Ungerstedt, U | 1 |
| Klawans, HL; Paleologos, N | 1 |
| Ahmed, SR; Shalet, SM | 1 |
| Bymaster, FP; Kornfeld, EC; Nichols, CL; Reid, LR; Wong, DT | 1 |
| Casey, DE | 1 |
| Blackwell, RE | 1 |
| Diamond, SG; Markham, CH; Treciokas, LJ | 1 |
| Hamill, R; Kurlan, R; Levy, R; Macik, B; Miller, C; Shoulson, I | 1 |
| Chhablani, R; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Jankovic, J | 3 |
| Goldstein, M; Lieberman, AN | 1 |
| Pepperell, RJ | 1 |
| Gopinathan, G; Lieberman, AN; Neophytides, A | 1 |
| Agid, Y; Dubois, B | 1 |
| Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
| Ewing, AG; Kuhr, WG; Near, JA; Wightman, RM | 1 |
| Askenasy, JJ; Yahr, MD | 2 |
| Baeyens, L; De Meirleir, K; Holmann, W; L'Hermite, M; L'Hermite-Balériaux, M; Olbrecht, J | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Babitsky, G; Cooper, P; Flamm, E; Kleinberg, DL; Niemann, W; Valensi, Q | 1 |
| Bogaert, MG; Dupont, AG; Lefebvre, RA | 1 |
| Besser, GM; Bouloux, PM; Grossman, A; Loneragan, R; Rees, LH; Wass, JA | 1 |
| Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA | 1 |
| Fuller, RW; Hymson, DL; Hynes, MD; Langer, DH; Pearson, DV | 1 |
| Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Walker, R | 1 |
| Mattox, JH | 1 |
| Garbin, CP; Greene, SB; Hollingsworth, EM; Mathews, D | 1 |
| Lloyd, RV; Nath, V; Schmidt, K | 1 |
| Jiang, DH | 1 |
| Burton, K; Calne, DB | 1 |
| Dhahir, P; Lemberger, L; Rubin, A | 1 |
| Cannon, JG; Demopoulos, BJ; Flynn, JR; Long, JP; Sharabi, FM | 1 |
| Lees, AJ; Stern, GM | 1 |
| Butt, WR; Franks, S; Horrocks, PM; London, DR; Lynch, SS | 2 |
| Fuller, RW; Snoddy, HD | 5 |
| Asano, T; Goldstein, M; Markey, K; Passeltiner, P; Rabey, JM | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Perry, KW | 1 |
| Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Fuller, RW; Perry, KW | 2 |
| Gianutsos, G; Palmeri, JL | 1 |
| Hall, JL; Root, MA; Schmidt, MJ | 1 |
| Bystritsky, A; Engel, J; Goldstein, M; Lieberman, A; Mino, S; Regev, I | 1 |
| Ku, BS; Takeuchi, H | 1 |
| Burke, JA; Chang, FW; Potter, DE | 1 |
| Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP | 2 |
| Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M | 1 |
| Creese, I; De Lean, A; Sibley, DR | 1 |
| Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
| Herrera-Marschitz, M; Hyttel, J; Ungerstedt, U | 1 |
| Hahn, RA | 1 |
| Barrett, RJ; Lokhandwala, MF | 3 |
| Fuller, RW; Perry, KW; Snoddy, HD | 1 |
| Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ | 1 |
| Glatt, S; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD | 1 |
| Isaacs, AJ | 1 |
| Debusschere, PM; Deschepper, C; Gillet, C; L'Hermite, M | 1 |
| Blackwell, RE; Bradley, EL; Rodgers-Neame, NT | 1 |
| McCormick, K; Sriwatanakul, K; Woolf, P | 1 |
| Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
| Fenton, HM; Gerhardt, S; Leszczak, E; Liebman, JM | 1 |
| De Bruyne, H; Jeanty, P; Lowenthal, A; Van den Kerchove, M | 1 |
| Demenge, P; Fage, D; Feuerstein, C; Guerin, B; Scatton, B | 1 |
| Koller, WC | 1 |
| Cote, L; Fahn, S; Ilson, J; Mayeux, R; Stern, Y | 1 |
| Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R | 2 |
| Login, IS | 1 |
| Fage, D; Scatton, B | 1 |
| Fahn, S; Jiang, DH; Reches, A; Wagner, HR | 1 |
| Agid, Y; Barroche, G; de Smet, Y; Lhermitte, F; Mear, JY; Weber, M | 1 |
| Fahn, S; Jackson-Lewis, V; Reches, A; Wagner, HR; Yablonskaya-Alter, E | 1 |
| Glantz, R; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| de Vries, JB; Feenstra, MG; Goedemoed, JH; Horn, AS; Rollema, H; Sumners, C | 1 |
| Cook, D; Kendall-Taylor, P; Upstill-Goddard, G | 1 |
| Bymaster, FP; Fuller, RW; Kornfeld, EC; Perry, KW; Reid, LR; Wong, DT | 1 |
| Jadhav, AL; Lokhandwala, MF; Sapru, HN; Willett, RN | 1 |
| Greene, SB; Hollingsworth, EM; Mathews, D | 1 |
| Diamond, SG; Markham, CH | 2 |
| Davis, PJ; Kerr, KM; Smith, RV | 2 |
| Côté, L; Fahn, S; Ilson, J | 1 |
| Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A | 2 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Thompson, C | 1 |
| Deconinck, I; Gillet, C; L'Hermite, M; Legros, JJ; Waucquez, JL | 1 |
| Jandhyala, BS; Kivlighn, SD; Lokhandwala, MF | 1 |
| Cavero, I; Giudicelli, JF; Lefevre-Borg, F; Lhoste, F; Richer, C; Sabatier, C | 1 |
| Bergstrom, DA; Bromley, SD; Walters, JR | 1 |
| Angeby, K; Ogren, SO; Rodebjer, A | 1 |
| Du Vivier, A; Monk, BE; Parkes, JD | 1 |
| Clemens, JA; Phebus, LA | 2 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
| Cavero, I; Lefèvere-Borg, F; Massingham, R | 1 |
| Greising, J; Kleinberg, DL; Kupersmith, M; Lieberman, A; Neophytides, A; Todd, J | 1 |
| Kaiser, DL; MacLeod, RM; Perryman, RL; Rogol, AD; Thorner, MO | 1 |
| Noonan, JJ; Rose, DP | 1 |
| Hall, K; Johnston, DG; Kendall-Taylor, P; Prescott, RW | 1 |
| Johnson, KM; Leventer, SM | 1 |
| Ford, J; Jackson, JA; Jankovic, J | 1 |
| Mountjoy, KG; Rose, DP | 1 |
| Boissier, JR; Dumont, C; Euvrard, C; Labrie, F; Laurent, J; Oberlander, C | 1 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, D; Quinn, NP; Sheehy, MP | 1 |
| Cote, LJ; Fahn, S; Ilson, J; Mayeux, R; Snider, SR | 1 |
| Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B | 1 |
| Bemis, KG; Clemens, JA; Fuller, RW; Mason, NR; Snoddy, HD | 1 |
| Boyd, AE; Bryan, N; Frantz, AG; George, A; Greising, J; Hamilton, D; Hilal, S; Kleinberg, DL; Seltzer, T; Sommers, CJ; Wardlaw, S | 1 |
| Glantz, RH; Glatt, SL; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Asano, T; Goldstein, M; Lew, JY; Lieberman, A; Makman, MH; Rosenfeld, MR | 1 |
| Klawans, HL; Tanner, CM | 1 |
| Cavero, I | 1 |
| Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Ahlenius, S; Engel, J; Larsson, K; Svensson, L | 1 |
| Johnels, B | 1 |
| Debusschere, P; L'Hermite, M | 1 |
| Thompson, C | 1 |
| Clemens, JA; Fuller, RW; Hynes, MD | 1 |
| Callaghan, JT; Crabtree, R; Lemberger, L | 1 |
| Callaghan, JT; Cleary, RE; Crabtree, R; Lemberger, L | 1 |
| Goldstein, M; Kleinberg, D; Kupersmith, M; Leibowitz, M; Lieberman, A; Neophytides, A; Pact, V | 1 |
| Besser, GM; Delitala, G; Grossman, A; Hathway, NR; Yeo, T | 1 |
| González, ER | 1 |
| Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO | 1 |
| Reid, LR; Wong, DT | 1 |
| Arbilla, S; Langer, SZ; Lehmann, J | 1 |
| Goldstein, M; Gopinathan, G; Kupersmith, M; Leibowitz, M; Lieberman, A; Mehl, S; Neophytides, A | 1 |
| Bach, NJ; Bymaster, FP; Kau, D; Kornfeld, EC; Lane, PT; Wong, DT | 1 |
| Goldstein, M; Makman, MH; Rosenfeld, MR | 1 |
| Granata, R; Jenner, P; Jolkkonen, J; Marsden, CD | 1 |
| Mark, MH; Sage, JI | 1 |
| Lamm, MC; Russell, VA; Taljaard, JJ | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO; Widman, M | 1 |
| Arai, N; Fukuyama, J; Isaji, M; Kuno, S; Miyata, H; Mizuta, E | 1 |
| Arai, N; Isaji, M; Itoh, F; Kojima, M; Miyagi, M; Taya, F; Ujiie, A | 1 |
| Conner, P; Fried, G | 1 |
| Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Brannan, T; Prikhojan, A; Yahr, MD | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R | 1 |
| Gekht, AB | 1 |
| Bain, PG; Navan, P | 1 |
| Clarke, CE; Guttman, M | 1 |
| Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M | 1 |
| Bankowski, BJ; Zacur, HA | 1 |
| Amad, M; Dunyach, JJ; Hughes, N; Paul, G; Splendore, M; Winnik, W | 1 |
| Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P | 1 |
| Cosyns, B; De Sutter, J; Decoodt, P; Flamez, A; Moerman, C; Muyldermans, L; Santens, P; Schoors, D; Van Camp, G; Van Zandijcke, M; Weytjens, C | 1 |
| Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S | 1 |
| Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP | 1 |
| Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Abs, R; Verhelst, J | 1 |
| Molitch, ME | 1 |
| Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML | 1 |
| Burger, E; Härtter, S; Kvernmo, T | 1 |
| Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH | 1 |
| Roth, BL | 1 |
| Andersohn, F; Garbe, E; Haverkamp, W; Schade, R; Suissa, S | 1 |
| Antonini, A; Gatto, G; Gentile, R; Pezzoli, G; Tesei, S; Zanettini, R | 2 |
| Erginöz, E; Kenangil, G; Koldas, L; Ozekmekçi, S; Sahin, T | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Senol, MG; Togrol, RE | 1 |
| Fuhrmann, JT; Simonis, G; Strasser, RH | 1 |
| Antonini, A; Poewe, W | 1 |
| Arcoraci, V; Morgante, L; Savica, R; Tari, M; Trifirò, G | 1 |
| Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
| Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C | 1 |
| Andersohn, F; Garbe, E | 1 |
| Sherlock, M; Steeds, R; Toogood, AA | 1 |
| Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H | 1 |
| Pullan, PT | 1 |
| Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH | 1 |
| Hornyak, M; Kohnen, R; Kriston, L; Riemann, D; Scholz, H; Trenkwalder, C | 1 |
| Kubota, K; Ooba, N; Yamaguchi, T | 1 |
| Ikeda, S; Ishizaki, T; Morikawa, K; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H | 1 |
| Aurora, RN; Bista, SR; Casey, KR; Kristo, DA; Lamm, CI; Rosenberg, RS; Rowley, JA; Tracy, SL; Zak, RS | 1 |
| Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R | 1 |
| Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Ikeda, S; Ishizaki, T; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H; Yamamoto, M | 1 |
| Bianchini, E; Bramanti, P; Cilia, R; Ciurleo, R; de Luise, C; Di Lorenzo, G; Ilardi, M; Italiano, D; Pezzoli, G; Polimeni, G; Rijnbeek, P; Ross, D; Stocchi, F; Sturkenboom, M; Trifirò, G; Vacca, L; Zanettini, R | 1 |
25 review(s) available for pergolide and ergoline
| Article | Year |
|---|---|
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
Topics: Animals; Apomorphine; Basal Ganglia; Benzazepines; Dextroamphetamine; Dopamine Antagonists; Electrophysiology; Ergolines; Globus Pallidus; Haloperidol; Ketanserin; Neurons; Pergolide; Piperidines; Quinpirole; Rats; Receptors, Dopamine; Substantia Nigra | 1986 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Diagnosis and management of prolactinomas.
Topics: Adenoma; Adult; Diagnosis, Differential; Ergolines; Female; Follow-Up Studies; Galactorrhea; Genital Diseases, Female; Humans; Hypophysectomy; Hypothyroidism; Infertility, Female; Pergolide; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Tomography, X-Ray Computed; Visual Field Tests | 1985 |
Long-term use of dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors | 1985 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II: Sites and mechanisms of action of dopamine receptor agonists.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Ergolines; Heart Rate; Hypertension; Models, Biological; Pergolide; Rats; Receptors, Dopamine; Vascular Resistance | 1982 |
Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin | 1998 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
Dopamine receptor agonists for treating prolactinomas.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2002 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Dopamine agonist monotherapy in Parkinson's disease.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Dopamine agonist therapy for hyperprolactinemia.
Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles | 2003 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
Pharmacologic resistance in prolactinoma patients.
Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2 | 2005 |
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine | 2006 |
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.
Topics: Antiparkinson Agents; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Drug Combinations; Echocardiography; Ergolines; Ergot Alkaloids; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Product Surveillance, Postmarketing | 2007 |
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2007 |
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents | 2009 |
Dopamine agonists for restless legs syndrome.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Levodopa; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Severity of Illness Index | 2011 |
The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.
Topics: Academies and Institutes; Benzothiazoles; Cabergoline; Carbamates; Dopamine Agents; Ergolines; Evidence-Based Medicine; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Peripheral Nervous System Diseases; Pramipexole; Restless Legs Syndrome; Sleep Medicine Specialty; United States; Venous Insufficiency | 2012 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
19 trial(s) available for pergolide and ergoline
| Article | Year |
|---|---|
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Pergolide; Prolactin; Prospective Studies; Random Allocation; Time Factors | 1986 |
Double-blind assessment of potential pergolide-induced cardiotoxicity.
Topics: Aged; Bradycardia; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Ergolines; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Prospective Studies | 1986 |
Double-blind trial of pergolide for Parkinson's disease.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1985 |
Long-term experience with pergolide therapy of advanced parkinsonism.
Topics: Aged; Ambulatory Care; Antiparkinson Agents; Clinical Trials as Topic; Drug Administration Schedule; Ergolines; Female; Hospitalization; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Shy-Drager Syndrome; Time Factors | 1985 |
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease.
Topics: Aged; Clinical Trials as Topic; Electrocardiography; Ergolines; Female; Heart; Heart Diseases; Humans; Male; Middle Aged; Myocardial Contraction; Parkinson Disease; Pergolide | 1985 |
Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Ergolines; Gait; Humans; Levodopa; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Pergolide; Random Allocation | 1985 |
Pergolide mesylate inhibits exercise-induced prolactin release in man.
Topics: Adult; Dopamine Antagonists; Ergolines; Hematocrit; Humans; Male; Middle Aged; Pergolide; Physical Exertion; Pituitary Gland, Anterior; Prolactin; Running | 1985 |
Pergolide and lisuride for levodopa-induced oscillations.
Topics: Clinical Trials as Topic; Ergolines; Female; Humans; Lisuride; Male; Parkinson Disease; Pergolide | 1981 |
Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.
Topics: Adult; Aged; Antiparkinson Agents; Bulbar Palsy, Progressive; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Placebos | 1983 |
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation | 1983 |
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
Topics: Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide; Sleep; Time Factors | 1983 |
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
Pergolide mesylate: its effects on circulating anterior pituitary hormones in man.
Topics: Adult; Antiparkinson Agents; Ergolines; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Pergolide; Pituitary Hormones, Anterior; Prolactin; Thyrotropin | 1981 |
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin | 2002 |
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome | 2004 |
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency | 2007 |
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
213 other study(ies) available for pergolide and ergoline
| Article | Year |
|---|---|
Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy.
Topics: Animals; Antiparkinson Agents; Ergolines; Guinea Pigs; Parkinson Disease; Pergolide; Rats | 1979 |
[Selective analyzers of dopamine D2 receptors modulate serotonin metabolism in the striatum and nucleus accumbens of the rat brain during blockade of dopaminergic impulse flow].
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Lisuride; Male; Nucleus Accumbens; Pergolide; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Serotonin | 1992 |
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium | 1992 |
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats | 1992 |
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1991 |
Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart.
Topics: Acetylcholine; Animals; Apomorphine; Bradycardia; Bromocriptine; Decerebrate State; Dopamine Agents; Electric Stimulation; Ergolines; Heart; Heart Rate; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vagus Nerve | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
Topics: Acetylcholine; Animals; Biogenic Amines; Brain; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Emetics; Ergolines; Male; Motor Activity; Pergolide; Prolactin; Quinolines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values; Stereotyped Behavior | 1989 |
Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Clonidine; Ergolines; Male; Mice; Motor Activity; Pergolide; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Dopamine; Reserpine; Sulpiride | 1989 |
Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
Topics: Acetylcholine; Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Ergolines; Haloperidol; Homovanillic Acid; Male; Naphthalenes; Pergolide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Sodium Oxybate; Tetrahydronaphthalenes; Tyrosine 3-Monooxygenase | 1985 |
Neuroleptic drugs and their action on different neuronal pathways.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Ergolines; gamma-Aminobutyric Acid; Humans; Motor Activity; Neural Pathways; Pergolide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 1985 |
Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Butyrophenones; Dopamine; Ergolines; Glycols; Homovanillic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1985 |
Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Appetite Depressants; Benzazepines; Electric Stimulation; Ergolines; Humans; Hydroxydopamines; Male; Oxidopamine; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Sympathectomy, Chemical; Time Factors | 1985 |
Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Azepines; Corpus Striatum; Depression, Chemical; Dopamine; Ergolines; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Pergolide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Neurotransmitter; Synaptosomes; Tyrosine 3-Monooxygenase | 1985 |
Effects of dopaminomimetics on the secretion of VIP-like immunoreactivity in conscious dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Apomorphine; Benzazepines; Dogs; Ergolines; Nitroglycerin; Pergolide; Piperidines; Prazosin; Receptors, Dopamine; Somatostatin; Vasoactive Intestinal Peptide | 1986 |
Of mice and men: the extension of animal models to the clinical evaluation of new drugs.
Topics: Animals; Drug Evaluation; Drug Evaluation, Preclinical; Ergolines; Fluoxetine; Humans; Models, Biological; Pergolide; Pharmacology, Clinical; Rats | 1986 |
Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease.
Topics: Adult; Aged; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1988 |
Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Ergolines; Evoked Potentials; Glutamates; Glutamic Acid; Male; Pergolide; Potassium; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Synaptosomes | 1988 |
Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats.
Topics: Animals; Corticosterone; Dopamine; Dopamine Agents; Ergolines; Male; Oxazines; Pergolide; Pharmaceutical Vehicles; Quinolines; Quinpirole; Rats; Rats, Inbred Strains | 1988 |
Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Ergolines; Hydroxydopamines; Ketanserin; Male; Motor Activity; Oxidopamine; Pergolide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior | 1985 |
Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Topics: Anesthesia; Animals; Blood Pressure; Clonidine; Denervation; Dogs; Electric Stimulation; Ergolines; Female; Heart; Heart Rate; Hemodynamics; Hypertension; Male; Norepinephrine; Pergolide; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Vagotomy; Vascular Resistance; Vasoconstriction | 1985 |
Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Clonidine; Diuresis; Dose-Response Relationship, Drug; Ergolines; Male; Pergolide; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
Topics: Animals; Apomorphine; Cats; Clonidine; Ergolines; In Vitro Techniques; Lisuride; Male; Muscle Contraction; Mydriatics; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Vas Deferens | 1985 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
Topics: Bromocriptine; Dopamine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Pergolide; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1986 |
The pituitary gland in primate mammary development: evidence that prolactin is not essential.
Topics: Animals; Ergolines; Estradiol; Female; Growth Hormone; Hypophysectomy; Macaca mulatta; Macaca nemestrina; Male; Mammary Glands, Animal; Pergolide; Pituitary Gland; Prolactin; Sexual Maturation; Thyrotropin-Releasing Hormone | 1986 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.
Topics: Animals; Apomorphine; Benzazepines; Ergolines; Male; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation | 1985 |
Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
Topics: Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Ergolines; Humans; Male; Motor Activity; Pergolide; Phenethylamines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism | 1985 |
Functional classification of different dopamine receptors.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Dominance, Cerebral; Dopamine; Ergolines; Flupenthixol; gamma-Aminobutyric Acid; Hydroxydopamines; Kainic Acid; Oxidopamine; Pergolide; Picrotoxin; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Synapses | 1985 |
Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Brain; Ergolines; Humans; Hydroxydopamines; Oxidopamine; Pergolide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1985 |
[Clinical study of pergolide in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide | 1985 |
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Ergolines; Lisuride; Male; Metergoline; Methiothepin; Naphthalenes; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Reflex, Startle; Tetrahydronaphthalenes | 1985 |
Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Azepines; Behavior, Animal; Benzazepines; Brain; Dialysis; Dopamine; Ergolines; Homovanillic Acid; Isomerism; Male; Motor Activity; Neurons; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Time Factors | 1988 |
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Topics: Animals; Brain; Corticosterone; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Heart; Lysergic Acid; Male; Membranes; Muscle, Smooth, Vascular; Pergolide; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Trachea | 1988 |
SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Body Temperature; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1986 |
Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Calcium; Corpus Striatum; Domperidone; Dopamine; Ergolines; Pergolide; Potassium; Quinpirole; Rats; Sulpiride; Synaptosomes; Tetrodotoxin | 1987 |
Mesulergine and pergolide in previously untreated Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Domperidone; Ergolines; Female; Humans; Male; Parkinson Disease; Pergolide | 1987 |
Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
Topics: Animals; Cholecystokinin; Corpus Striatum; Dextroamphetamine; Dopamine; Ergolines; In Vitro Techniques; Kinetics; Male; Pergolide; Potassium; Rats; Rats, Inbred Strains; Sulpiride | 1986 |
Long-term efficacy of pergolide in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1986 |
The effect of apomorphine and pergolide on the potassium-evoked overflow of GABA in rat striatum studied by microdialysis.
Topics: Animals; Apomorphine; Corpus Striatum; Dialysis; Ergolines; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Perfusion; Pergolide; Potassium; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
Discordant responses of prolactinoma to two different dopamine agonists.
Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Clonidine; Corpus Striatum; Dopamine; Dopamine Antagonists; Enzyme Activation; Ergolines; Pergolide; Quinolines; Rats; Receptors, Dopamine; Spiperone | 1986 |
Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cebus; Dextroamphetamine; Dopamine; Ergolines; Haloperidol; Humans; Mastication; Pergolide; Receptors, Dopamine; Stereotyped Behavior | 1985 |
Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Benzazepines; Clopenthixol; Dopamine; Dose-Response Relationship, Drug; Ergolines; Flupenthixol; Hydroxydopamines; Hypothalamus; Male; Motor Activity; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1985 |
Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Corpus Striatum; Denervation; Ergolines; Hydroxydopamines; Injections; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation | 1985 |
Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Denervation; Ergolines; Hydroxydopamines; Injections; Male; Nucleus Accumbens; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation | 1985 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
Efficacy of pergolide and mesulergine.
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1986 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |
Amphetamine attenuates the stimulated release of dopamine in vivo.
Topics: Animals; Benztropine; Biological Transport; Cattle; Caudate Nucleus; Dextroamphetamine; Dopamine; Electric Stimulation; Electrochemistry; Ergolines; Haloperidol; In Vitro Techniques; Male; Pergolide; Rats; Reserpine; Synaptic Vesicles | 1985 |
Long-term study of pergolide in Parkinson's disease.
Topics: Adult; Aged; Disability Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.
Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM | 1985 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administration.
Topics: Animals; Ergolines; Estradiol; Female; Growth Hormone; Hypophysectomy; Macaca; Male; Mammary Glands, Animal; Papio; Pergolide; Pituitary Gland; Prolactin; Sexual Maturation | 1985 |
Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.
Topics: Animals; Antiparkinson Agents; Apomorphine; Drug Interactions; Ergolines; Female; Haloperidol; Hindlimb; Male; Pergolide; Rats; Regional Blood Flow; Vasoconstriction; Yohimbine | 1985 |
Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia.
Topics: Adenoma; Adult; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
The effect of dopamine agonist therapy on large functionless pituitary tumours.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies | 1985 |
Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats.
Topics: Amphetamine; Animals; Dopamine; Dose-Response Relationship, Drug; Ergolines; Hypertension; Motor Activity; Pergolide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine | 1985 |
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.
Topics: Adult; Aged; Alanine Transaminase; Antiparkinson Agents; Aspartate Aminotransferases; Cognition Disorders; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nausea; Neurologic Examination; Parkinson Disease; Pergolide; Vasculitis | 1985 |
Dopamine agonists in hyperprolactinemia.
Topics: Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Pergolide | 1985 |
Behavioral effects of pergolide mesylate on food intake and body weight.
Topics: Animals; Appetite Depressants; Body Weight; Ergolines; Feeding Behavior; Female; Hysterectomy; Ovariectomy; Pergolide; Rats; Time Factors | 1985 |
Effects of pergolide on diethylstilbestrol-induced rat pituitary hyperplasia.
Topics: Animals; Diethylstilbestrol; Ergolines; Female; Growth Hormone; Hyperplasia; Microscopy, Electron; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred F344 | 1985 |
[Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Parkinson Disease; Pergolide; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Physiologic disposition of pergolide.
Topics: Adult; Animals; Bromocriptine; Chromatography, High Pressure Liquid; Ergolines; Feces; Humans; Male; Middle Aged; Pergolide | 1981 |
Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives.
Topics: Animals; Ergolines; Ergot Alkaloids; Locomotion; Pergolide; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1981 |
Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
Topics: Administration, Oral; Adult; Bromocriptine; Depression, Chemical; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Pergolide; Prolactin; Time Factors | 1981 |
Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists.
Topics: Animals; Antiparkinson Agents; Corticosterone; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Metergoline; Mianserin; Pergolide; Rats; Rats, Inbred Strains; Spiperone | 1981 |
Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by partial ergoline.
Topics: Animals; Antiparkinson Agents; Cell Membrane; Corpus Striatum; Ergolines; Hydroxydopamines; Male; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Synapses; Synaptosomes; Tyrosine 3-Monooxygenase | 1981 |
Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
Topics: Animals; Antiparkinson Agents; Dopamine Antagonists; Epinephrine; Ergolines; Haloperidol; Hypothalamus; Kinetics; Male; Pergolide; Rats; Rats, Inbred Strains; Spiperone | 1982 |
Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone.
Topics: Animals; Butyrophenones; Corticosterone; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Ergolines; Male; Pergolide; Rats; Rats, Inbred Strains; Spiperone | 1982 |
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Effect of pergolide on MOPEG sulphate levels in rat brain regions.
Topics: Animals; Brain Chemistry; Ergolines; Glycols; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Pergolide; Rats; Rats, Inbred Strains | 1983 |
Effects of three dopamine agonists on cage climbing behavior.
Topics: Animals; Behavior, Animal; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Motor Activity; Pergolide | 1983 |
Dopamine agonist-induced hyperglycemia in rats: structure-activity relationships and mechanisms of action.
Topics: Animals; Blood Glucose; Dopamine; Ergolines; Glucagon; Glycogen; Insulin; Liver Glycogen; Male; Muscles; Pergolide; Picolinic Acids; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tryptophan | 1983 |
Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
Topics: Adrenergic alpha-Agonists; Animals; Dopamine; Ergolines; Haplorhini; Humans; Neurons; Norepinephrine; Parkinson Disease; Pergolide; Quinpirole; Rats | 1983 |
Effects of synthetic ergot derivatives on the two identifiable giant neurons, sensitive to dopamine, of Achatina fulica Ferussac.
Topics: Animals; Antiparkinson Agents; Chemical Phenomena; Chemistry; Dopamine; Electrophysiology; Ergolines; Ergot Alkaloids; Lisuride; Neurons; Pergolide; Snails | 1983 |
Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.
Topics: Administration, Topical; Animals; Bromocriptine; Domperidone; Ergolines; Eye; Ganglia, Sympathetic; Intraocular Pressure; Male; Pergolide; Rabbits; Sympathectomy | 1984 |
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes | 1984 |
Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding Sites; Denervation; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Hydroxydopamines; Kainic Acid; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Stereotaxic Techniques | 1984 |
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1984 |
Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine.
Topics: Adrenal Medulla; Animals; Apomorphine; Cells, Cultured; Dopamine; Epinephrine; Ergolines; Glucose; Indans; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Yohimbine | 1984 |
Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Antipsychotic Agents; Appetite Depressants; Benzamides; Benzazepines; Catalepsy; Clopenthixol; Ergolines; Flupenthixol; Humans; Hydroxydopamines; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1984 |
Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.
Topics: Animals; Binding, Competitive; Butaclamol; Cattle; Cell Membrane; Computers; Ergolines; Guanylyl Imidodiphosphate; Kinetics; Pergolide; Pituitary Gland, Anterior; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone | 1982 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
The dopamine D-1 antagonist SCH 23390 inhibits apomorphine but not pergolide induced rotation.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Ergolines; Hydroxydopamines; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Rotation | 1984 |
Inhibitory effects of pergolide on peripheral adrenergic neurotransmission in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Hemodynamics; Hypertension; Male; Pergolide; Peripheral Nerves; Rats; Rats, Inbred Strains; Spinal Cord; Sympathetic Nervous System; Synaptic Transmission | 1981 |
Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.
Topics: Animals; Antiparkinson Agents; Dogs; Ergolines; Female; Heart; Heart Rate; Male; Norepinephrine; Pergolide; Receptors, Dopamine; Sulpiride; Sympathetic Nervous System; Synaptic Transmission; Yohimbine | 1982 |
Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover.
Topics: Animals; Dopamine; Dopamine beta-Hydroxylase; Ergolines; Imidazoles; Male; Myocardium; Norepinephrine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1982 |
Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.
Topics: Adult; Ergolines; Female; Humans; Hypogonadism; Male; Menstruation Disturbances; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Time Factors | 1983 |
Effectiveness of pergolide in hyperprolactinaemia.
Topics: Adult; Antiparkinson Agents; Ergolines; Female; Humans; Pergolide; Prolactin | 1983 |
Treatment of hyperprolactinaemic patients with pergolide.
Topics: Adolescent; Adult; Amenorrhea; Dose-Response Relationship, Drug; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Oligomenorrhea; Pergolide; Pituitary Neoplasms; Prolactin; Time Factors | 1983 |
Long-term monolayer culture of human anterior pituitary cells: functional validation of a method.
Topics: Bromocriptine; Cells, Cultured; Ergolines; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Methods; Pergolide; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1984 |
Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists.
Topics: Child; Dopamine; Ergolines; Female; Humans; Hyperthyroidism; Pergolide; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Clozapine; Ergolines; Humans; Hydroxydopamines; Male; Oxidopamine; Pergolide; Piperidines; Postural Balance; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sympathectomy, Chemical | 1984 |
Pergolide therapy in Parkinson's disease.
Topics: Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
Topics: Acetylcholine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Ergolines; Haloperidol; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1984 |
Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
Topics: Animals; Corpus Striatum; Ergolines; Guinea Pigs; Haloperidol; Male; Membranes; Pergolide; Receptors, Dopamine; Spiperone | 1984 |
Evidence that striatal efferents relate to different dopamine receptors.
Topics: Animals; Apomorphine; Corpus Striatum; Dose-Response Relationship, Drug; Efferent Pathways; Ergolines; Kainic Acid; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Substantia Nigra | 1984 |
Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Corticosterone; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Homovanillic Acid; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Pergolide therapy for Parkinson's disease: neurobehavioral changes.
Topics: Adult; Aged; Behavior; Ergolines; Female; Humans; Male; Middle Aged; Nervous System; Parkinson Disease; Pergolide; Psychological Tests | 1984 |
Long-term treatment with pergolide: decreased efficacy with time.
Topics: Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1984 |
Pergolide versus bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide | 1984 |
Hypophysectomy fails to affect the supersensitivity of striatal dopamine target cells induced by prolonged haloperidol treatment.
Topics: Acetylcholine; Animals; Apomorphine; Body Weight; Brain Chemistry; Corpus Striatum; Dopamine; Ergolines; Haloperidol; Humans; Hypophysectomy; Male; Pergolide; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1984 |
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Ergolines; Homovanillic Acid; Humans; Limbic System; Male; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1984 |
Pergolide in the treatment of Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
Topics: Animals; Corpus Striatum; Denervation; Ergolines; Levodopa; Male; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Behavioural and biochemical studies with the benzamide sulpiride in rats.
Topics: Animals; Apomorphine; Brain; Dialysis; Ergolines; Flupenthixol; gamma-Aminobutyric Acid; Glutamates; Motor Activity; Pergolide; Picrotoxin; Rats; Receptors, Dopamine; Rotation; Scopolamine; Sulpiride | 1984 |
Pergolide in Parkinson's disease.
Topics: Aged; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Ergolines; Homovanillic Acid; Indoles; Male; Molindone; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Models, Neurological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Longterm pergolide treatment of acromegaly.
Topics: Acromegaly; Adult; Ergolines; Female; Glucose; Growth Hormone; Humans; Male; Middle Aged; Pergolide; Prolactin | 1983 |
Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.
Topics: Acetylcholine; Animals; Cholinergic Fibers; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ergolines; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Stereoisomerism | 1983 |
Involvement of central dopamine receptors in the hypotensive action of pergolide.
Topics: Animals; Blood Pressure; Brain; Ergolines; Male; Pergolide; Phentolamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Sympathetic Nervous System | 1983 |
VMN lesion deficits in lordosis: partial reversal with pergolide mesylate.
Topics: Animals; Castration; Dose-Response Relationship, Drug; Ergolines; Estradiol; Female; Pergolide; Progesterone; Rats; Receptors, Dopamine; Sexual Behavior, Animal; Ventromedial Hypothalamic Nucleus | 1983 |
Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Cardiovascular System; Central Nervous System; Dogs; Ergolines; Female; Heart Rate; Hypertension; Male; Norepinephrine; Pergolide; Peripheral Nerves; Receptors, Dopamine; Renal Circulation; Sulpiride; Vascular Resistance | 1983 |
Evaluating the evaluations: or how to weigh the scales of parkinsonian disability.
Topics: Drug Evaluation; Ergolines; Humans; Parkinson Disease; Pergolide | 1983 |
Microbial transformations of pergolide to pergolide sulfoxide and pergolide sulfone.
Topics: Aspergillus; Biotransformation; Ergolines; Fermentation; Helminthosporium; Mitosporic Fungi; Oxidation-Reduction; Pergolide | 1983 |
Painful dystonic spasms in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Female; Humans; Hypotension; Male; Middle Aged; Nausea; Pain; Parkinson Disease; Pergolide; Spasm | 1984 |
Pergolide and lisuride in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1984 |
Pergolide in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Domperidone; Ergolines; Humans; Levodopa; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Pergolide | 1984 |
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Pergolide for pituitary tumors secreting prolactin or growth hormone.
Topics: Acromegaly; Ergolines; Female; Growth Hormone; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin | 1984 |
Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Topics: Animals; Antiparkinson Agents; Atropine; Blood Pressure; Brain; Dogs; Ergolines; Female; Hindlimb; Male; Norepinephrine; Pergolide; Receptors, Dopamine; Sulpiride; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 1984 |
Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Topics: Adrenalectomy; Animals; Antiparkinson Agents; Autonomic Nervous System; Blood Pressure; Clonidine; Decerebrate State; Dose-Response Relationship, Drug; Ergolines; Heart Rate; Hypertension; Male; Methysergide; Norepinephrine; Pergolide; Phenoxybenzamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spinal Cord; Vascular Resistance; Vasopressins | 1984 |
Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
Topics: Action Potentials; Anesthesia, General; Animals; Apomorphine; Chloral Hydrate; Dopamine; Drug Interactions; Electric Stimulation; Ergolines; Globus Pallidus; Haloperidol; Lisuride; Lysergic Acid Diethylamide; Male; Neurons; Pergolide; Rats; Rats, Inbred Strains | 1984 |
Suppression of REM rebound by Pergolide.
Topics: Aged; Antiparkinson Agents; Electroencephalography; Ergolines; Humans; Male; Parkinson Disease; Pergolide; Sleep Deprivation; Sleep, REM | 1984 |
The 'presynaptic' blocking potency of sulpiride and haloperidol in the rat is age-dependent.
Topics: Age Factors; Animals; Ergolines; Haloperidol; Male; Models, Neurological; Models, Psychological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1984 |
Erythromelalgia following pergolide administration.
Topics: Aged; Antiparkinson Agents; Ergolines; Erythromelalgia; Female; Humans; Male; Pergolide | 1984 |
Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate.
Topics: Animals; Ascorbic Acid; Brain; Corpus Striatum; Dextroamphetamine; Dialysis; Dopamine; Electrochemistry; Ergolines; Male; Pergolide; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease.
Topics: Animals; Circadian Rhythm; Ergolines; Female; Haplorhini; Humans; Macaca mulatta; Parkinson Disease; Pergolide; Prolactin | 1980 |
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Ergolines; Female; Growth Hormone; Hypophysectomy; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats | 1982 |
Reduction in size of prolactin-secreting tumours in men treated with pergolide.
Topics: Antineoplastic Agents; Ergolines; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin | 1982 |
Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline.
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Calcium; Choline; Corpus Striatum; Dose-Response Relationship, Drug; Ergolines; Male; Oxotremorine; Pergolide; Phencyclidine; Rats; Rats, Inbred Strains | 1983 |
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas.
Topics: Animals; Ergolines; Female; Growth Hormone; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats; Rats, Inbred Strains; Thyroid Hormones; Thyroidectomy | 1983 |
Comparative study of central dopaminergic properties of RU 29717 (N-propyl-9-oxaergoline) and pergolide.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Behavior, Animal; Corpus Striatum; Dogs; Dopamine; Ergolines; Female; Male; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Lisuride and pergolide in Parkinson's disease.
Topics: Aged; Disability Evaluation; Dose-Response Relationship, Drug; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Sleep | 1983 |
The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease.
Topics: Adult; Aged; Cardiovascular System; Ergolines; Female; Heart Diseases; Heart Ventricles; Humans; Hypotension, Orthostatic; Male; Middle Aged; Myocardial Contraction; Parkinson Disease; Pergolide; Pulse; Sick Sinus Syndrome | 1983 |
Pergolide treatment in parkinsonism.
Topics: Adult; Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Respiration Disorders | 1983 |
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1983 |
Dopa dose-dependent sexual deviation.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide | 1983 |
Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anesthetized vs unanesthetized rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Ascorbic Acid; Brain; Chloral Hydrate; Consciousness; Dopamine; Electric Conductivity; Ergolines; Male; Pergolide; Rats; Rats, Inbred Strains | 1983 |
Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain Chemistry; Corticosterone; Domperidone; Ergolines; Homovanillic Acid; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1983 |
Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone.
Topics: Acromegaly; Adenoma; Ergolines; Female; Fertility; Growth Hormone; Humans; Male; Menstruation; Pergolide; Pituitary Neoplasms; Prolactin; Testosterone; Tomography, X-Ray Computed | 1983 |
Pergolide mesylate and idiopathic Parkinson disease.
Topics: Adolescent; Adult; Carbidopa; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide | 1982 |
Further studies with pergolide in Parkinson disease.
Topics: Adult; Aged; Carbidopa; Confusion; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1982 |
Interaction of pergolide with central dopaminergic receptors.
Topics: Adenylyl Cyclases; Animals; Behavior, Animal; Binding, Competitive; Cattle; Cerebral Decortication; Chlorocebus aethiops; Corpus Striatum; Ergolines; Guanosine Triphosphate; Hot Temperature; Male; Pergolide; Rats; Receptors, Dopamine; Spiperone; Tegmentum Mesencephali; Tremor | 1980 |
Pergolide mesylate: new therapy for Parkinson disease.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide | 1982 |
Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
Topics: Animals; Blood Pressure; Clonidine; Electric Stimulation; Epinephrine; Ergolines; Heart Rate; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spinal Cord; Sympathetic Nervous System | 1982 |
The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation; Time Factors | 1982 |
Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.
Topics: 4-Butyrolactone; Animals; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Furans; Haloperidol; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension.
Topics: Animals; Antihypertensive Agents; Dogs; Electric Stimulation; Ergolines; Female; Hemodynamics; Hypertension; Male; Neurons, Afferent; Pergolide; Receptors, Dopamine; Renal Circulation; Sulpiride | 1982 |
Effects of pergolide and bromocriptine on male rat sexual behavior.
Topics: Animals; Bromocriptine; Ergolines; Male; Pergolide; Rats; Sexual Behavior, Animal | 1982 |
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei | 1982 |
Potent 48 hours inhibition of prolactin secretion by pergolide in hyperprolactinaemic women.
Topics: Adolescent; Adult; Antiparkinson Agents; Ergolines; Female; Humans; Middle Aged; Pergolide; Prolactin; Time Factors | 1982 |
Anwesenheit: psychopathology and clinical associations.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Epilepsy, Temporal Lobe; Ergolines; Grief; Humans; Lisuride; Male; Middle Aged; Pergolide; Schizophrenic Psychology; Sleep Wake Disorders | 1982 |
Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ergolines; Homovanillic Acid; Male; Motor Activity; Pergolide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Synapses | 1982 |
Pergolide, a potent long-acting dopamine-receptor agonist.
Topics: Adult; Blood Pressure; Bromocriptine; Circadian Rhythm; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Growth Hormone; Hormones; Humans; Male; Middle Aged; Myocardial Contraction; Pergolide; Perphenazine; Prolactin; Receptors, Dopamine; Time Factors | 1980 |
The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
Topics: alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Clozapine; Drug Interactions; Emetics; Ergolines; Guinea Pigs; Haloperidol; Humans; Hydroxydopamines; Male; Methyltyrosines; Pergolide; Rats; Stereotyped Behavior | 1980 |
Clinical response of patients with galactorrhea to pergolide, a potent, long-acting dopaminergic ergot derivative.
Topics: Adult; Amenorrhea; Drug Evaluation; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Pergolide; Pregnancy; Prolactin | 1981 |
Treatment of advanced Parkinson disease with pergolide.
Topics: Aged; Arrhythmias, Cardiac; Brain; Dopamine; Double-Blind Method; Ergolines; Humans; Levodopa; Middle Aged; Neurons; Parkinson Disease; Pergolide; Random Allocation | 1981 |
Two new dopamine agonists that are long acting in vivo but short acting in vitro.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; In Vitro Techniques; Male; Pergolide; Prolactin; Rats; Secretory Rate; Time Factors | 1980 |
Parkinson's disease: new drugs help but no cure on the horizon.
Topics: Antiparkinson Agents; Ergolines; Humans; Lisuride; Parkinson Disease; Pergolide | 1981 |
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine | 1981 |
Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
Topics: Adenylyl Cyclases; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Enzyme Activation; Ergolines; Guanosine Triphosphate; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Membranes; Pergolide; Rats; Rats, Inbred Strains; Synaptosomes | 1980 |
Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate.
Topics: Animals; Ascorbic Acid; Cats; Caudate Nucleus; Corpus Striatum; Dopamine; Electric Stimulation; Ergolines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Species Specificity | 1981 |
Cardiac effects of pergolide.
Topics: Aged; Antiparkinson Agents; Arrhythmias, Cardiac; Carbidopa; Drug Therapy, Combination; Ergolines; Heart; Heart Rate; Humans; Levodopa; Middle Aged; Pergolide | 1981 |
High-performance liquid chromatographic determination of pergolide and its metabolite, pergolide sulfoxide, in microbial extracts.
Topics: Biotransformation; Chromatography, High Pressure Liquid; Ergolines; Helminthosporium; Pergolide; Sulfoxides | 1981 |
Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Homovanillic Acid; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1981 |
Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
Topics: Animals; Brain; Cattle; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Pergolide; Rats; Receptors, Dopamine; Subcellular Fractions; Synaptosomes; Time Factors | 1980 |
Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP.
Topics: Adenylyl Cyclases; Animals; Corpus Striatum; Enzyme Activation; Ergolines; Guanosine Triphosphate; Male; Pergolide; Rats; Receptors, Dopamine | 1980 |
Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dopamine Agonists; Enkephalins; Ergolines; Gene Expression; In Situ Hybridization; Male; Neostriatum; Pergolide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P | 1995 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Lack of interaction between alpha 2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Binding, Competitive; Brimonidine Tartrate; Dopamine; Electric Stimulation; Ergolines; GTP-Binding Proteins; Haloperidol; In Vitro Techniques; Male; Nucleus Accumbens; Pergolide; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Signal Transduction; Sulpiride | 1993 |
Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
Topics: Animals; Body Temperature; Chromatography, High Pressure Liquid; Dopamine D2 Receptor Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Pergolide; Quinpirole; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides | 1993 |
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Macaca fascicularis; Parkinson Disease, Secondary; Pergolide | 1995 |
Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
Topics: Animals; Benzazepines; Binding, Competitive; Bromocriptine; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; In Vitro Techniques; Male; Pergolide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1996 |
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination | 1998 |
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 2000 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease.
Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Tolerance; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Time | 2002 |
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2003 |
High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities.
Topics: Animals; Cabergoline; Cattle; Chromatography, High Pressure Liquid; Dopamine Agonists; Ergolines; Pergolide; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2004 |
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Cardiopulmonary complications of ergot-derivative dopamine agonists.
Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone | 2004 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Drugs and valvular heart disease.
Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Pergolide; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Dopamine agonists and the risk of cardiac-valve regurgitation.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cabergoline; Case-Control Studies; Cohort Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
Topics: Aged; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Parkinson Disease; Pergolide; Regression Analysis; Risk; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Ultrasonography | 2007 |
Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Tricuspid Valve Insufficiency | 2007 |
Parkinson's drugs linked to heart valve trouble.
Topics: Antiparkinson Agents; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Pergolide | 2007 |
Dopamine agonists and valvular heart disease.
Topics: Antipsychotic Agents; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Methysergide; Pergolide; Receptor, Serotonin, 5-HT2B; Retroperitoneal Fibrosis; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists | 2007 |
Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.
Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Parkinson Disease; Patient Selection; Pergolide; Pramipexole; Research Design; Sex Factors | 2007 |
Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent.
Topics: Aged; Antiparkinson Agents; Cabergoline; Cardiovascular Diseases; Dopamine Agonists; Ergolines; Female; Humans; Male; Parkinson Disease; Pergolide; Treatment Outcome | 2008 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors | 2009 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.
Topics: Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Heart Valve Diseases; Heart Valves; Humans; Hyperprolactinemia; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency | 2009 |
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography | 2009 |
Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.
Topics: Adult; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Italy; Male; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Ultrasonography | 2011 |
The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Ergolines; Health Knowledge, Attitudes, Practice; Humans; Parkinson Disease; Pergolide | 2009 |
The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008.
Topics: Cabergoline; Databases, Factual; Dopamine Agonists; Drug Prescriptions; Drug Utilization Review; Ergolines; Government Regulation; Heart Valve Diseases; Humans; Insurance Claim Review; Japan; Legislation, Drug; Parkinson Disease; Pergolide; Regression Analysis; Ultrasonography | 2011 |
Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease.
Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Drug Labeling; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Incidence; Japan; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Risk Factors | 2011 |
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult | 2013 |
Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010.
Topics: Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Drug Prescriptions; Ergolines; Female; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 2014 |
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.
Topics: Aged; Antiparkinson Agents; Cabergoline; Cohort Studies; Echocardiography; Ergolines; Female; Guideline Adherence; Heart Valve Diseases; Heart Valves; Humans; Incidence; Italy; Male; Middle Aged; Parkinson Disease; Pergolide; Practice Guidelines as Topic; Prevalence; Retrospective Studies; Risk Factors; Supranuclear Palsy, Progressive | 2015 |